Drimane meroterpenoids have attracted
an increasing amount of attention
in the discovery of therapeutically important probes, while the laggard
synthetic accessibility is a conspicuous challenge. A new paradigm
merging decarboxylative borylation and Suzuki coupling was developed
as a powerful platform. Key features include the mild conditions,
good chemoselectivity, operational facility, scalability, and easy
availability of the coupling partners. This practical strategy enables
the expedient formal synthesis of a large number of natural products
and rapid generation of analogues.